{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:03:22Z","timestamp":1793865802910,"version":"4.6.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002300","name":"Rivkin Center for Ovarian Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006438","name":"Office of the Assistant Secretary for Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.redox.2018.11.009","type":"journal-article","created":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T11:49:17Z","timestamp":1542455357000},"page":"101051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["GPx3 supports ovarian cancer progression by manipulating the extracellular redox environment"],"prefix":"10.1016","volume":"25","author":[{"given":"Beth L.","family":"Worley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Mardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rameez","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly E.","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyushi Gupta","family":"Vallur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asvelt","family":"Nduwumwami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua I.","family":"Warrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick F.","family":"Timmins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua P.","family":"Kesterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9b\u00e9cca","family":"Pha\u00ebton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6114-6714","authenticated-orcid":false,"given":"Vonn","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Endres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthikeyan","family":"Mythreye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Aird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Hempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.redox.2018.11.009_bib1","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"3\u20134","key":"10.1016\/j.redox.2018.11.009_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1155\/2001\/418547","article-title":"Ovarian carcinoma and serous effusions. Changing views regarding tumor progression and review of current literature","volume":"23","author":"Davidson","year":"2001","journal-title":"Anal. Cell.Pathol. J.\u00a0Eur. Soc. Anal. Cell. Pathol."},{"issue":"10","key":"10.1016\/j.redox.2018.11.009_bib3","doi-asserted-by":"crossref","first-page":"e46858","DOI":"10.1371\/journal.pone.0046858","article-title":"Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors","volume":"7","author":"Latifi","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.redox.2018.11.009_bib4","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","article-title":"Mechanisms of transcoelomic metastasis in ovarian cancer","volume":"7","author":"Tan","year":"2006","journal-title":"Lancet Oncol."},{"issue":"7577","key":"10.1016\/j.redox.2018.11.009_bib5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature15726","article-title":"Oxidative stress inhibits distant metastasis by human melanoma cells","volume":"527","author":"Piskounova","year":"2015","journal-title":"Nature"},{"issue":"7260","key":"10.1016\/j.redox.2018.11.009_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature08268","article-title":"Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment","volume":"461","author":"Schafer","year":"2009","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.redox.2018.11.009_bib7","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1158\/0008-5472.CAN-12-2482","article-title":"Antioxidant enzymes mediate survival of breast cancer cells deprived of extracellular matrix","volume":"73","author":"Davison","year":"2013","journal-title":"Cancer Res."},{"issue":"7354","key":"10.1016\/j.redox.2018.11.009_bib8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature10189","article-title":"Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis","volume":"475","author":"DeNicola","year":"2011","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.redox.2018.11.009_bib9","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1172\/JCI78031","article-title":"ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis","volume":"125","author":"Dey","year":"2015","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.redox.2018.11.009_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/187152011795255911","article-title":"Manganese superoxide dismutase (Sod2) and redox-control of signaling events that drive metastasis","volume":"11","author":"Hempel","year":"2011","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"10.1016\/j.redox.2018.11.009_bib11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fonc.2013.00256","article-title":"Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research","volume":"3","author":"Ahmed","year":"2013","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.redox.2018.11.009_bib12","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/1097-0142(19940401)73:7<1882::AID-CNCR2820730718>3.0.CO;2-R","article-title":"Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer","volume":"73","author":"Plante","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.redox.2018.11.009_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1471-2407-11-210","article-title":"Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients","volume":"11","author":"Lane","year":"2011","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.redox.2018.11.009_bib14","doi-asserted-by":"crossref","first-page":"9653","DOI":"10.1074\/jbc.M306662200","article-title":"Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells","volume":"279","author":"Fang","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"30","key":"10.1016\/j.redox.2018.11.009_bib15","doi-asserted-by":"crossref","first-page":"24990","DOI":"10.1074\/jbc.M112.340083","article-title":"Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells","volume":"287","author":"Mukherjee","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2018.11.009_bib16","doi-asserted-by":"crossref","first-page":"2873030","DOI":"10.1155\/2017\/2873030","article-title":"Markers of oxidative stress and inflammation in ascites and plasma in patients with platinum-sensitive, platinum-resistant, and platinum-refractory epithelial ovarian cancer","volume":"2017","author":"Cant\u00f3n-Romero","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"17","key":"10.1016\/j.redox.2018.11.009_bib17","doi-asserted-by":"crossref","first-page":"8043","DOI":"10.1158\/0008-5472.CAN-07-0648","article-title":"Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis","volume":"67","author":"Yu","year":"2007","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.redox.2018.11.009_bib18","first-page":"405","article-title":"An 8-gene signature, including methylated and down-regulated glutathione peroxidase 3, of gastric cancer","volume":"36","author":"Zhang","year":"2010","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.redox.2018.11.009_bib19","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.3892\/or.2014.3152","article-title":"Downregulation of glutathione peroxidase 3 is associated with lymph node metastasis and prognosis in cervical cancer","volume":"31","author":"Zhang","year":"2014","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.redox.2018.11.009_bib20","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2174\/138920371604150429154840","article-title":"Silencing GPX3 expression promotes tumor metastasis in human thyroid cancer","volume":"16","author":"Zhao","year":"2015","journal-title":"Curr. Protein Pept. Sci."},{"issue":"1","key":"10.1016\/j.redox.2018.11.009_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2011.05.013","article-title":"GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response","volume":"309","author":"Chen","year":"2011","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.redox.2018.11.009_bib22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1080\/15592294.2016.1265711","article-title":"GPX3 promoter methylation predicts platinum sensitivity in colorectal cancer","volume":"12","author":"Pelosof","year":"2017","journal-title":"Epigenetics"},{"issue":"Suppl 1","key":"10.1016\/j.redox.2018.11.009_bib23","doi-asserted-by":"crossref","first-page":"S522","DOI":"10.1007\/s12032-010-9659-0","article-title":"Immunohistochemical evidence for the over-expression of glutathione peroxidase 3 in clear cell type ovarian adenocarcinoma","volume":"28","author":"Lee","year":"2011","journal-title":"Med Oncol."},{"issue":"6","key":"10.1016\/j.redox.2018.11.009_bib24","first-page":"1299","article-title":"Glutathione peroxidase 3 is a candidate mechanism of anticancer drug resistance of ovarian clear cell adenocarcinoma","volume":"20","author":"Saga","year":"2008","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.redox.2018.11.009_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1074\/mcp.M800313-MCP200","article-title":"Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers","volume":"8","author":"Kuk","year":"2009","journal-title":"Mol. Cell. Proteom."},{"issue":"2 Pt 1","key":"10.1016\/j.redox.2018.11.009_bib26","doi-asserted-by":"crossref","first-page":"C367","DOI":"10.1152\/ajpcell.1994.266.2.C367","article-title":"Human kidney proximal tubules are the main source of plasma glutathione peroxidase","volume":"266","author":"Avissar","year":"1994","journal-title":"Am. J. Physiol."},{"issue":"5","key":"10.1016\/j.redox.2018.11.009_bib27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.redox.2018.11.009_bib28","doi-asserted-by":"crossref","first-page":"e98479","DOI":"10.1371\/journal.pone.0098479","article-title":"Bioenergetic analysis of ovarian cancer cell lines: profiling of histological subtypes and identification of a mitochondria-defective cell line","volume":"9","author":"Dier","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.redox.2018.11.009_bib29","doi-asserted-by":"crossref","first-page":"e0132572","DOI":"10.1371\/journal.pone.0132572","article-title":"Moles of a substance per cell is a highly informative dosing metric in cell culture","volume":"10","author":"Doskey","year":"2015","journal-title":"PLoS One"},{"issue":"38","key":"10.1016\/j.redox.2018.11.009_bib30","doi-asserted-by":"crossref","first-page":"13604","DOI":"10.1073\/pnas.0506390102","article-title":"Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues","volume":"102","author":"Chen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"21","key":"10.1016\/j.redox.2018.11.009_bib31","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1073\/pnas.0702854104","article-title":"Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo","volume":"104","author":"Chen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.redox.2018.11.009_bib32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.freeradbiomed.2015.03.033","article-title":"Role of labile iron in the toxicity of pharmacological ascorbate","volume":"84","author":"Du","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.redox.2018.11.009_bib33","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1593\/neo.05328","article-title":"Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis","volume":"7","author":"Lee","year":"2005","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.redox.2018.11.009_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood-2013-03-487884","article-title":"Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma","volume":"122","author":"Kaiser","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.redox.2018.11.009_bib35","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1084\/jem.20102386","article-title":"A role for GPx3 in activity of normal and leukemia stem cells","volume":"209","author":"Herault","year":"2012","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.redox.2018.11.009_bib36","first-page":"3869","article-title":"Coordinately up-regulated genes in ovarian cancer","volume":"61","author":"Hough","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2018.11.009_bib37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1757-2215-4-18","article-title":"Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression","volume":"4","author":"Agnani","year":"2011","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.redox.2018.11.009_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.redox.2017.02.010","article-title":"Increased static and decreased capacity oxidation-reduction potentials in plasma are predictive of metabolic syndrome","volume":"12","author":"Bobe","year":"2017","journal-title":"Redox Biol."},{"issue":"8","key":"10.1016\/j.redox.2018.11.009_bib39","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1089\/neu.2008.0816","article-title":"Plasma oxidation-reduction potential and protein oxidation in traumatic brain injury","volume":"26","author":"Rael","year":"2009","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.redox.2018.11.009_bib40","doi-asserted-by":"crossref","first-page":"204615","DOI":"10.1155\/2015\/204615","article-title":"Assessment of eccentric exercise-induced oxidative stress using oxidation-reduction potential markers","volume":"2015","author":"Stagos","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.redox.2018.11.009_bib41","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1158\/1078-0432.CCR-09-1713","article-title":"Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer","volume":"16","author":"Du","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"222","key":"10.1016\/j.redox.2018.11.009_bib42","doi-asserted-by":"crossref","first-page":"222ra18","DOI":"10.1126\/scitranslmed.3007154","article-title":"High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy","volume":"6","author":"Ma","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.redox.2018.11.009_bib43","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccell.2017.02.018","article-title":"O2(-) and H2O2-mediated disruption of fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate","volume":"31","author":"Schoenfeld","year":"2017","journal-title":"Cancer Cell."},{"issue":"4","key":"10.1016\/j.redox.2018.11.009_bib44","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0009-2797(74)90019-2","article-title":"The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer","volume":"9","author":"Cameron","year":"1974","journal-title":"Chem.-Biol. Interact."},{"issue":"2","key":"10.1016\/j.redox.2018.11.009_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3945\/an.110.000109","article-title":"Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries","volume":"2","author":"Levine","year":"2011","journal-title":"Adv. Nutr."},{"issue":"11","key":"10.1016\/j.redox.2018.11.009_bib46","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/annonc\/mdn377","article-title":"Phase I clinical trial of i.v. ascorbic acid in advanced malignancy","volume":"19","author":"Hoffer","year":"2008","journal-title":"Ann. Oncol. : Off. J. Eur. Soc. Med. Oncol. \/ ESMO"},{"issue":"1","key":"10.1016\/j.redox.2018.11.009_bib47","doi-asserted-by":"crossref","first-page":"e29794","DOI":"10.1371\/journal.pone.0029794","article-title":"Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer","volume":"7","author":"Monti","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2018.11.009_bib48","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1038\/srep05955","article-title":"Extracellular iron diminishes anticancer effects of vitamin C: an in vitro study","volume":"4","author":"Mojic","year":"2014","journal-title":"Sci. Rep."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231718308917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231718308917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:08:09Z","timestamp":1761977289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231718308917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":48,"alternative-id":["S2213231718308917"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2018.11.009","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GPx3 supports ovarian cancer progression by manipulating the extracellular redox environment","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2018.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101051"}}